{"id":"W2586716181","doi":"10.1093/ecco-jcc/jjx002.033","title":"OP034 Efficacy and safety of abrilumab in subjects with moderate to severe ulcerative colitis: results of a phase 2b, randomised, double-blind, multiple-dose, placebo-controlled study","year":2017,"lang":"en","type":"article","venue":"Journal of Crohn s and Colitis","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"","keywords":"Medicine; Ulcerative colitis; Placebo; Internal medicine; Clinical endpoint; Gastroenterology; Pharmacokinetics; Phases of clinical research; Surgery; Randomized controlled trial; Clinical trial; Pathology; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002906294,0.001158583,0.002451523,0.0003505427,0.0003670944,0.0007856067,0.000733113,0.001515256,0.003826748],"category_scores_gemma":[0.001663388,0.0005238181,0.001343253,0.0003772563,0.0008052434,0.0006920198,0.0003217134,0.001829221,0.0007145015],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003909941,"about_ca_system_score_gemma":0.0009819102,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004468701,"about_ca_topic_score_gemma":0.0009205675,"domain_scores_codex":[0.9992076,0.0004281364,0.00006196651,0.0001071082,0.00009102659,0.0001042369],"domain_scores_gemma":[0.9988488,0.000315656,0.0002651075,0.0000776415,0.0001235294,0.0003693948],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9230251,0.02136868,0.002627855,0.001235093,0.00117607,0.0001147983,0.0001097116,0.000259603,0.01461696,0.00006096111,0.001003366,0.03440192],"study_design_scores_gemma":[0.746697,0.2382999,0.01217815,0.00004280548,0.0006742307,0.0001071486,0.00002814506,0.0002813226,0.0007845499,0.00006202798,0.0008238043,0.00002080373],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9907734,0.004368667,0.0005089639,0.0003911925,0.0001336322,0.001977086,0.0007003402,0.00009928399,0.001047527],"genre_scores_gemma":[0.9909453,0.00219538,0.001255907,0.00107007,0.0003131971,0.001796967,0.0009971972,0.00002262173,0.001403346],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003826748,"threshold_uncertainty_score":0.01537013,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01437862903108685,"score_gpt":0.2887442405795698,"score_spread":0.274365611548483,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}